ArticleCureus2024
Role of Vitamin D in Asthma Control: A Cross-Sectional Study of the Indian Adult Population.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Bronchial asthma is a major health problem both globally and in developing countries like India. This heterogenous disease is characterised by chronic airway inflammation and hyperresponsiveness to various extrinsic and intrinsic stimuli. The innate and adaptive immune mechanisms play an important role in the pathogenesis of asthma. Vitamin D through its immunomodulatory function on innate and acquired immunity can affect asthma control and its exacerbation. In this study, serum levels of vitamin D in bronchial asthma patients were determined, and their correlation with asthma symptom control and exacerbation was studied. Materials and methods Serum vitamin D levels of patients diagnosed with bronchial asthma (based on their history and reversible obstruction in spirometry) who reported for follow-up at the Respiratory outpatient department of a tertiary care hospital in Western Maharashtra, India, were tested after obtaining informed consent. A questionnaire was given to assess their asthma control and exacerbations. Based on their symptom control over the past four weeks, they were categorized into well-controlled (WC), partially controlled (PC), and uncontrolled (UC) asthma groups. Results Serum vitamin D levels were determined for 70 patients diagnosed with asthma, of which 10 patients fell into the UC group, 28 into the PC group, and 32 into the WC group. Among the 10 patients in the WC group, vitamin D levels were deficient in six (60%) patients, insufficient in two (20%) patients, and normal in two (20%) patients. Among the 28 patients in the PC group, vitamin D levels were deficient in 19 (67%) patients, insufficient in seven (25%) patients, and normal in two (7.1%) patients. Among the 32 patients in the UC group, vitamin D levels were deficient in 17 (53.1%) patients, insufficient in 10 (31.2%) patients, and normal in five (15.6%) patients. Conclusions Although vitamin D deficiency was highly prevalent among Indian adult asthma patients, there was no statistically significant relationship between serum vitamin D levels and asthma control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.